Activities per year
Activities
- 43 results
Search results
-
Risque thrombotique des oestroprogestatifs
Douxfils, J. (Speaker)
3 Apr 2025Activity: Talk or presentation types › Invited talk
-
Does E4/DRSP have minimal impact on hemostasis and VTE risk? The evidence is growing
Douxfils, J. (Speaker)
20 Mar 2025Activity: Talk or presentation types › Invited talk
-
Towards safer and more responsible use of estrogen-based oral contraceptives
Douxfils, J. (Speaker)
22 Mar 2025Activity: Talk or presentation types › Invited talk
-
Lower reporting of venous thromboembolisms events with natural estrogen-based COCs compared to ethinylestradiol containing pills: A disproportionality analysis of the Eudravigilance database.
Douxfils, J. (Speaker)
22 Mar 2025Activity: Talk or presentation types › Invited talk
-
Risque thrombotique des oestroprogestatifs : quoi de neuf ?
Douxfils, J. (Speaker)
13 Mar 2025Activity: Talk or presentation types › Invited talk
-
Risque thromboembolique veineux de l’add back thérapie
Douxfils, J. (Speaker)
13 Mar 2025Activity: Talk or presentation types › Invited talk
-
Vers une utilisation plus sûre et responsable des contraceptifs oraux à base d'estrogène
Douxfils, J. (Speaker)
11 Feb 2025Activity: Talk or presentation types › Invited talk
-
The normalized Activated Protein C sensitivity ratio (nAPCsr): the INR of the gynecologist for a safer prescription of estrogen-containing products
Douxfils, J. (Speaker)
11 Dec 2024Activity: Talk or presentation types › Invited talk
-
Estetrol - an estrogen through life: Cardiovascular impact and the risk of VTE
Douxfils, J. (Speaker)
4 Jun 2024Activity: Talk or presentation types › Invited talk
-
Thromboses associées aux contraceptifs hormonaux combinés: évaluation du risque et suivi thérapeutique par un nouveau test, le nAPCr
Douxfils, J. (Speaker)
27 Jun 2024Activity: Talk or presentation types › Invited talk
-
Risque de thrombose associés aux contraceptifs hormonaux combinés - pourquoi l’évaluation de la résistance à la protéine C activée, appelée nAPCsr, est-elle importante?
Douxfils, J. (Speaker)
20 Jun 2024Activity: Talk or presentation types › Invited talk
-
Is there a physiological explanation to VTE risk observed in epidemiological studies?
Douxfils, J. (Speaker)
1 May 2024Activity: Talk or presentation types › Invited talk
-
Is there new data to support the screening of women for hereditary thrombophilia before prescribing pills?
Douxfils, J. (Speaker)
1 May 2024Activity: Talk or presentation types › Invited talk
-
Thromboses associées aux contraceptifs hormonaux combinés: évaluation du risque et suivi thérapeutique par un nouveau test, le nAPCr
Douxfils, J. (Speaker)
18 Apr 2024Activity: Talk or presentation types › Invited talk
-
Risque de thrombose associés aux contraceptifs hormonaux combinés - pourquoi l’évaluation de la résistance à la protéine C activée, appelée nAPCsr, est-elle importante?
Douxfils, J. (Speaker)
16 Mar 2024Activity: Talk or presentation types › Invited talk
-
Cardiovascular safety: the point of view of the veins
Douxfils, J. (Speaker)
8 Mar 2024Activity: Talk or presentation types › Invited talk
-
Risque de thrombose associés aux contraceptifs hormonaux combinés - pourquoi l’évaluation de la résistance à la protéine C activée, appelée nAPCsr, est-elle importante?
Douxfils, J. (Speaker)
22 Feb 2024Activity: Talk or presentation types › Invited talk
-
Hormones-induced Coagulopathies — Evaluation of the Prothrombotic State Using a Global Coagulation Assay
Douxfils, J. (Speaker)
25 Jan 2024Activity: Talk or presentation types › Invited talk
-
Impact of progestagen alone or associated with estrogen on the coagulation: A state of the art in 2023
Douxfils, J. (Speaker)
1 Dec 2023Activity: Talk or presentation types › Invited talk
-
Hemostasis parameters with estetrol/drospirenone - why APC resistance matters
Douxfils, J. (Speaker)
30 Nov 2023Activity: Talk or presentation types › Invited talk
-
Combined Hormonal Contraceptives - Induced Coagulopathies Evaluation of the Prothrombotic State Using a Global Coagulation Assay
Douxfils, J. (Speaker) & Morimont, L. (Speaker)
4 Oct 2023Activity: Talk or presentation types › Invited talk
-
Donesta Partner Meeting : Acquired APC resistance as a marker for VTE, how does the estrogens differ?
Douxfils, J. (Keynote speaker)
4 Sept 2023 → 8 Sept 2023Activity: Talk or presentation types › Invited talk
-
Safety profile of E4: Recent advance and evidence
Douxfils, J. (Keynote speaker)
18 Sept 2023Activity: Talk or presentation types › Invited talk
-
Aquired APC-resistance as a marker for VTE, how reliable?
Douxfils, J. (Invited speaker)
27 Aug 2023Activity: Talk or presentation types › Invited talk
-
Évaluation du risque vasculaire des contraceptifs
Douxfils, J. (Invited speaker)
21 Jun 2023 → 23 Jun 2023Activity: Talk or presentation types › Invited talk
-
Risque induit par les oestrogènes de synthèse en clinique
Douxfils, J. (Invited speaker)
8 Jun 2023Activity: Talk or presentation types › Invited talk
-
Estétrol: une nouvelle ère dans la contraception
Douxfils, J. (Invited speaker)
11 Feb 2023Activity: Talk or presentation types › Invited talk
-
Thromboembolie veineuse et contraception orale: Quelle stratégie pour minimiser le risque?
Douxfils, J. (Invited speaker) & Morimont, L. (Speaker)
12 Jan 2023Activity: Talk or presentation types › Invited talk
-
Hormonal contraception and the risk of venous thrombosis – facts and myths
Douxfils, J. (Speaker)
18 Nov 2022Activity: Talk or presentation types › Invited talk
-
Acquired APC resistance as a marker for VTE, how reliable?
Douxfils, J. (Speaker)
7 Oct 2022Activity: Talk or presentation types › Invited talk
-
Method validation for haemostasis assays: Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women. An unmet clinical and regulatory need
Douxfils, J. (Speaker)
15 Sept 2022Activity: Talk or presentation types › Invited talk
-
Beeak-out Medical: Hemostasis and update on the Post Authorization Safety Study
Douxfils, J. (Speaker) & Chatel, G. (Speaker)
13 Sept 2022Activity: Talk or presentation types › Invited talk
-
Impact of E4 on hemostasis — Key messages to understand its unique safety profile
Douxfils, J. (Speaker)
13 Sept 2022Activity: Talk or presentation types › Invited talk
-
L’associazione Estetrolo/Drospirenone: approfondimento sui parametri ematocoagulativi | Why APC resistance matters?
Douxfils, J. (Speaker)
14 Jun 2022Activity: Talk or presentation types › Invited talk
-
Impact des traitements hormonaux sur l’hémostase et exploration biologique : développement et perspectives actuelles
Douxfils, J. (Speaker)
7 Jun 2022Activity: Talk or presentation types › Invited talk
-
Safety profile of E4: recent clinical evidence
Douxfils, J. (Speaker)
12 May 2022Activity: Talk or presentation types › Invited talk
-
Impact des traitements hormonaux sur l’hémostase et exploration biologique : développement et perspectives actuelles
Douxfils, J. (Speaker)
17 May 2022Activity: Talk or presentation types › Invited talk
-
Estétrol/drospirénone, le point de vue de l’hém(ost)ato(sio)logue
Douxfils, J. (Speaker)
26 Jan 2022Activity: Talk or presentation types › Invited talk
-
Estetrol (E4): Impact on hemostasis
Douxfils, J. (Invited speaker)
24 May 2021Activity: Talk or presentation types › Invited talk
-
Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory need
Douxfils, J. (Invited speaker) & Morimont, L. (Invited speaker)
4 Feb 2021Activity: Talk or presentation types › Invited talk
-
Restoring faith in COC - An important hemostasis update
Douxfils, J. (Speaker)
2 Dec 2020Activity: Talk or presentation types › Invited talk
-
Pilule et thrombose : risques et contrôle biologique
Douxfils, J. (Speaker)
14 Oct 2019Activity: Talk or presentation types › Invited talk
-
The Namur Thrombosis and Hemostasis Center A gathering of experts from laboratory, clinical and regulatory field
Douxfils, J. (Invited speaker)
19 Mar 2019Activity: Talk or presentation types › Invited talk